The sequencing landscape is changing more rapidly than ever before: The cost of sequencing is decreasing (welcome to the $100 genome) and patents are expiring. Recent assumptions around the choice of sequencing provider and equipment may no longer be accurate. How do you make sense of this new, suddenly dynamic sequencing ecosystem?
Our Advances in Genomic Sequencing ONLINE webinar series will help you with these questions, and others by:
- Sharing case studies on dissecting the most complex diseases, from cancer to neurodegenerative disorders using long and short reads
- Uncovering the benefits of using a combination of long and short-read sequencing technologies
- Giving you the latest insight into which patents are expiring, and which new players are entering the scene
** Please note, by registering for one webinar in the series you will automatically receive access to the subsequent webinar. **
– – – – –
Webinar 1: Exploring Long- and Short-Read Sequencing
Wednesday 30th November at 3pm GMT/ 4pm CET/ 10am EST
When is long-read sequencing best, and how long is long enough? How can we leverage both technologies to the best of their abilities to better understand the human genome?
Presentations:
- Population-scale assessment of structural variation in frontotemporal dementia
- Wouter De Coster, Research Associate, University of Antwerp & VIB
- The molecular screening and therapeutic study: A national precision oncology program
- David Thomas, Head of Genomic Cancer Medicine, Garvan Institute of Medical Research, Chief Executive Officer, Omico: Australian Genomic Cancer Medicine Centre, Conjoint Professor, St Vincent’s Clinical School, Faculty of Medicine, UNSW
- Long-read transcriptome sequencing reveals isoform diversity across human neurodevelopment
- Rosemary Bamford, Research Fellow, University of Exeter Medical School
– – – – –
Webinar 2: Panel Discussion: Exploring the changing sequencing landscape in 2022 and beyond
Wednesday 7th December at 3pm GMT/ 4pm CET/ 10am EST
The panellists will help you understand:
- The changing sequencing landscapes
- Novel (and exciting) technologies that are hitting the market, and when is best to use them
- Lessons learned from having completed the human genome
- Ethical and legal issues surrounding sequencing and data ownership
Panellists:
- David Smith, Emeritus Professor, Mayo Clinic
- Shawn Baker, Genomics Start-up Advisor/Investor/Consultant, SanDiegOmics
- Deanna Church, Independent Consultant, Dmchurch Bio, llc
- Michael Andrew Quail, Principal Scientific Manager, Sequencing R&D, Wellcome Sanger Institute
- Catalina Lopez-Correa, Chief Scientific Officer, Genome Canada
– – – – –
Register for Advances in Genomic Sequencing ONLINE here:
Speakers
Wouter De Coster, Research Associate, University of Antwerp & VIB
David Thomas, Head of Genomic Cancer Medicine, Chief Executive Officer, Conjoint Professor, Garvan Institute of Medical Research, Omico: Australian Genomic Cancer Medicine Centre, St Vincent's Clinical School, Faculty of Medicine, UNSW
Rosemary Bamford, Research Fellow, University of Exeter Medical School
David Smith, Emeritus Professor, Mayo Clinic
Shawn Baker, Genomics Start-up Advisor/Investor/Consultant, SanDiegOmics
Deanna Church, Independent Consultant, Dmchurch Bio, llc
Michael Andrew Quail, Principal Scientific Manager, Sequencing R&D, Wellcome Sanger Institute
Catalina Lopez-Correa, Chief Scientific Officer, Genome Canada
